Related Experiment Video
Updated: Dec 7, 2025

Subcutaneous Trigeminal Nerve Field Stimulation for Refractory Facial Pain
Published on: May 10, 2017
Motor Cortex Stimulation for Facial Pain
1Department of Neurological Surgery, Oregon Health & Science University, Portland, Oregon, USA.
Abstract:
Motor cortex stimulation (MCS) has been used in the treatment of intractable neuropathic facial pain for nearly 30 years. While efficacy rates have been noted as high as 88% in some studies, considerable variability in treatment response remains. Additionally, MCS is often cited as providing diminishing relief over time, and there are few long-term studies on efficacy. Complications are generally mild and include infection, hardware complication, seizure, and transient neurological deficit. Despite relatively minimal use, MCS remains a viable treatment option for the appropriately selected facial pain patients that have proved refractory to conservative management.
Insights
Motor cortex stimulation (MCS) offers a potential treatment for neuropathic facial pain, with some studies showing high efficacy. However, variable responses and diminishing relief over time necessitate further long-term investigation.
Area of Science:
- Neurosurgery
- Pain Management
- Neurology
Background:
- Motor cortex stimulation (MCS) has been utilized for intractable neuropathic facial pain for approximately 30 years.
- While some studies report high efficacy rates (up to 88%), significant variability in patient response persists.
Purpose of the Study:
- To review the efficacy and long-term outcomes of motor cortex stimulation for neuropathic facial pain.
- To highlight the variability in treatment response and potential diminishing relief over time.
Main Methods:
- Review of existing literature on motor cortex stimulation for neuropathic facial pain.
- Analysis of reported efficacy rates, long-term outcomes, and complications.
Main Results:
- Efficacy rates vary considerably, with some studies reporting up to 88% effectiveness.
- Diminishing relief over time is a noted concern, with limited long-term efficacy data available.
- Complications are generally mild, including infection, hardware issues, seizures, and transient neurological deficits.
Conclusions:
- Motor cortex stimulation remains a viable option for carefully selected patients with refractory neuropathic facial pain.
- Further long-term studies are needed to fully understand efficacy trends and optimize patient selection.
Related Concept Videos
Muscles for Facial Expressions
Motor Unit Stimulation
The latent period of contraction marks the onset of excitation-contraction coupling, when the action potential propagates across the sarcolemma, preparing the muscle fibers for contraction. As the fibers enter the contraction phase, the...

